Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 appears on the page; no changes to study details, eligibility criteria, or outcome measures are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedBanner notice about a lapse in government funding and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedThe updates add a glossary toggle and update page metadata, including a new 'Last Update Submitted that Met QC Criteria' field and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This appears to be a maintenance update and does not modify study information or essential content.SummaryDifference0.1%

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.